Sparc Technologies Ships First Commercial Graphene Order, Yet Shares Slip Toward Offer Price

Sparc Technologies stock falls 7.7% to AUD 0.18, near SPP price, despite first commercial ecosparc shipment and revenue growth.

The gap between operational progress and share price performance has rarely been wider for Sparc Technologies. On Wednesday, the Australian-listed company saw its stock fall 7.7% to AUD 0.1800, extending a volatile stretch that has left the shares roughly 57% below their 52-week high of AUD 0.4150, set in early May.

That slide comes at an awkward moment. The company's current share purchase plan (SPP), opened in late August, prices new shares at AUD 0.175 — a level the market price is now rapidly approaching. With the offer period running until September 24, the convergence of market price and subscription price suggests investors are weighing the dilutive impact of the capital raise against the company's recent commercial breakthroughs.

First Commercial Delivery Marks Strategic Turning Point

Just over a week ago, Sparc Technologies announced the completion of its first commercial shipment of ecosparc®, its graphene additive. The 160-kilogram delivery, produced at the company's Adelaide facility, was sent to an unnamed leading global manufacturer of protective coatings. The material is destined for use in a high-performance coating designed to resist corrosion and external stresses.

The shipment represents a decisive shift from research and development toward recurring revenue generation. It follows the May launch of two coating products enhanced with ecosparc®, and management has framed the delivery as the beginning of a transition from trial runs to sustained commercial sales. More than 20 active test programs with potential customers are currently underway worldwide, with several additional product launches targeted over the next six to twelve months.

The choice of a Tier-1 manufacturer as the first customer carries particular weight. It signals that the technology has gained traction at industrial scale, with applications relevant to shipping and infrastructure projects where protective coating performance is critical.

Financial Improvement and Portfolio Expansion

The operational momentum is reflected in the company's fiscal 2025 results, published on July 30. Revenue climbed 51.4% to AUD 2.15 million, while losses narrowed by 46.69% to AUD 2.28 million — evidence that the path toward profitability, while still distant, is at least trending in the right direction.

Beyond corrosion protection, Sparc Technologies is broadening its addressable market. The new SparcES™ product line targets specialized applications requiring electrostatic and conductive coatings, particularly for data centers and semiconductor manufacturing infrastructure. By integrating graphene into these coating systems, the company aims to achieve more precise control over surface electrical properties, leveraging expertise developed through its earlier product lines.

Hydrogen Ambitions Advance in Parallel

The graphene business is not the only technology platform in motion. Through its Sparc Hydrogen joint venture, the company is developing concentrated solar reactors in collaboration with Fortescue and the University of Adelaide. About a month ago, Sparc reported that testing with partner SunHydrogen had achieved over 10% efficiency in the direct conversion of solar energy into hydrogen. The technology agreement calls for testing specialized modules within Sparc Hydrogen's reactors to evaluate the scalability of green hydrogen production.

Market Reality Bites

For all the technological milestones, the share price remains under pressure from both the ongoing capital raise and technical correction. The stock currently trades about 21% below its 50-day moving average, underscoring the persistent volatility that has characterized the title throughout recent months.

The company's next financial figures and the outcome of the capital measure are expected in early October. Until then, investors face a familiar tension: a company delivering operational firsts while its equity continues to be priced for the risks of dilution rather than the promise of commercial scale.